212 related articles for article (PubMed ID: 27903900)
21. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.
Wang ET; Cody NA; Jog S; Biancolella M; Wang TT; Treacy DJ; Luo S; Schroth GP; Housman DE; Reddy S; Lécuyer E; Burge CB
Cell; 2012 Aug; 150(4):710-24. PubMed ID: 22901804
[TBL] [Abstract][Full Text] [Related]
23. Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy.
Rogalska Z; Sobczak K
Mol Ther Nucleic Acids; 2022 Dec; 30():438-448. PubMed ID: 36420218
[TBL] [Abstract][Full Text] [Related]
24. Alternative splicing regulation by Muscleblind proteins: from development to disease.
Fernandez-Costa JM; Llamusi MB; Garcia-Lopez A; Artero R
Biol Rev Camb Philos Soc; 2011 Nov; 86(4):947-58. PubMed ID: 21489124
[TBL] [Abstract][Full Text] [Related]
25. Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.
Grammatikakis I; Goo YH; Echeverria GV; Cooper TA
Nucleic Acids Res; 2011 Apr; 39(7):2769-80. PubMed ID: 21109529
[TBL] [Abstract][Full Text] [Related]
26. The CUGBP2 splicing factor regulates an ensemble of branchpoints from perimeter binding sites with implications for autoregulation.
Dembowski JA; Grabowski PJ
PLoS Genet; 2009 Aug; 5(8):e1000595. PubMed ID: 19680430
[TBL] [Abstract][Full Text] [Related]
27. Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function.
Nitschke L; Hu RC; Miller AN; Lucas L; Cooper TA
Nucleic Acids Res; 2023 Feb; 51(3):1245-1259. PubMed ID: 36617982
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
[TBL] [Abstract][Full Text] [Related]
29. Alternative Splicing Outcomes Across an RNA-Binding Protein Concentration Gradient.
Ellis JA; Hale MA; Cleary JD; Wang ET; Andrew Berglund J
J Mol Biol; 2023 Aug; 435(15):168156. PubMed ID: 37230319
[TBL] [Abstract][Full Text] [Related]
30. Combinatorial mutagenesis of MBNL1 zinc fingers elucidates distinct classes of regulatory events.
Purcell J; Oddo JC; Wang ET; Berglund JA
Mol Cell Biol; 2012 Oct; 32(20):4155-67. PubMed ID: 22890842
[TBL] [Abstract][Full Text] [Related]
31. The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.
Voss DM; Sloan A; Spina R; Ames HM; Bar EE
Cancer Res; 2020 Nov; 80(21):4681-4692. PubMed ID: 32928918
[TBL] [Abstract][Full Text] [Related]
32. Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility.
deLorimier E; Hinman MN; Copperman J; Datta K; Guenza M; Berglund JA
J Biol Chem; 2017 Mar; 292(10):4350-4357. PubMed ID: 28130447
[TBL] [Abstract][Full Text] [Related]
33. Developmental regulation of muscleblind-like (MBNL) gene expression in the chicken embryo retina.
Huang H; Wahlin KJ; McNally M; Irving ND; Adler R
Dev Dyn; 2008 Jan; 237(1):286-96. PubMed ID: 18095352
[TBL] [Abstract][Full Text] [Related]
34. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
35. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.
Batra R; Charizanis K; Manchanda M; Mohan A; Li M; Finn DJ; Goodwin M; Zhang C; Sobczak K; Thornton CA; Swanson MS
Mol Cell; 2014 Oct; 56(2):311-322. PubMed ID: 25263597
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitination of MBNL1 Is Required for Its Cytoplasmic Localization and Function in Promoting Neurite Outgrowth.
Wang PY; Chang KT; Lin YM; Kuo TY; Wang GS
Cell Rep; 2018 Feb; 22(9):2294-2306. PubMed ID: 29490267
[TBL] [Abstract][Full Text] [Related]
37. Dissecting domains necessary for activation and repression of splicing by Muscleblind-like protein 1.
Edge C; Gooding C; Smith CW
BMC Mol Biol; 2013 Dec; 14():29. PubMed ID: 24373687
[TBL] [Abstract][Full Text] [Related]
38. Cognate RNA-Binding Modes by the Alternative-Splicing Regulator MBNL1 Inferred from Molecular Dynamics.
González ÀL; Fernández-Remacha D; Borrell JI; Teixidó J; Estrada-Tejedor R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555788
[TBL] [Abstract][Full Text] [Related]
39. Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1.
Teplova M; Patel DJ
Nat Struct Mol Biol; 2008 Dec; 15(12):1343-51. PubMed ID: 19043415
[TBL] [Abstract][Full Text] [Related]
40. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
